NSB vs NXN

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

NSB

NEUROSCIEN FPO [NSB]

48LOW

NXN

NEXSEN LTD FPO [NXN]

48LOW

Score Breakdown

NSB NXN
Technical
36
70
Catalyst
50
55
Sentiment
50
50
Fundamental
70
72
Momentum
80
44
Risk Gate
46
42

Key Metrics

NSB Metric NXN
$27.3MMarket Cap$34.0M
221KAvg Volume (20d)335K
N/AShort InterestN/A
$0.26052-Week High$0.315
$0.03452-Week Low$0.130
+1.2%Daily Change+6.2%
$0.083Entry Price$0.170
-29.6%ROEN/A
N/AProfit MarginN/A

Active Signals

NSB Signals

●RSI drifting toward oversold territory — worth watching
●MACD crossed bearish — momentum is fading
●Trading below both moving averages — the trend is working against this one
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (18 quarters)
●4C filed 2026-01-29
●Very high P/S ratio (85.8x)
●Strong revenue growth (+129%)

NXN Signals

●MACD momentum is picking up steam
●Volume surging at 2.2x normal while price climbs — real buying conviction behind this move
●On a tear — up 17.2% over the last 5 days
●Volatility is expanding fast — choppy price action, so buckle up
●Adequate cash runway (8 quarters)
●Piotroski F-Score weak (3/9, low-confidence approx)
●Small-cap ($20-100M)
●CANSLIM S: Tight float (35%)

Ask Scout AI to compare NSB and NXN in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
NSB Full Analysis → NXN Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).